|Day Low/High||17.03 / 18.25|
|52 Wk Low/High||7.88 / 21.77|
Walgreens will now divest up to 1,200 Rite Aid stores to Fred's Pharmacy.
The activist investor could be agitating behind-the-scenes to have Fred's sold after it picks up hundreds of stores required by the FTC to consumate a Walgreen-Rite Aid deal
Fred's, Inc. ("Fred's Pharmacy" or "the Company") (NASDAQ: FRED) today announced that its Board of Directors has declared a quarterly cash dividend of $0.
Billionaire investors appear to see good times ahead with a fellow billionaire in the White House.
David Einhorn's hedge fund, Greenlight Capital, disclosed fresh positions in four stocks.
With nearly $800 million invested in the stock, Apple remains David Einhorn's top investment, but a he's buying up notable positions in some other companies, too.
Einhorn picked up new positions in Syngenta and others.
In recent trading, shares of Fred's Inc. have crossed above the average analyst 12-month target price of $15.50, changing hands for $16.01/share.
Fred's Inc. ("Fred's Pharmacy" or the "Company") (NASDAQ:FRED) today announced three additions to its senior management team.
Fred's Inc. ("Fred's Pharmacy" or "the Company") (NASDAQ: FRED) today reported sales for the four-week fiscal month of January 2017, fourth quarter 2016 and fiscal year 2016 ended January 28, 2017.
Fred's Inc. ("Fred's Pharmacy" or the "Company") (NASDAQ:FRED) today issued the following statement regarding the agreement between Walgreens Boots Alliance, Inc.
Will this deal ever satisfy the FTC? Plus what Jim Cramer thinks.
Investors in Fred's Inc. saw new options become available this week, for the March 17th expiration.
Here are Tuesday's top research calls, including an upgrade for Silgan and downgrades for Apple, Aetna and DineEquity.
Will the merger with Walgreens go through? Investors -- even Jim Cramer -- can't be sure, and that is affecting the drug store stock.
Here's how to trade seven of the most active stocks on the market Monday.
TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,200 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: AGI, FRED, IXYS, XRX Downgrades: ATRO, ENFC Initiations: None Read on to get TheStreet Quant Ratings' detailed report:
Rite Aid shares fell in dramatic fashion on Friday.
Rite Aid shares are tanking on reports that the FTC may not approve Walgreens Boots Alliance's acquisition of the company.
The company's consistency is a testament to management’s commitment to and focus on continued cost improvements and self-help initiatives exclusive of the Rite Aid merger.
Walgreens has delivered earnings per share beats in eight out of the last nine quarters.
Fred's Inc. ("Fred's Pharmacy" or "the Company") (NASDAQ: FRED) today reported sales for the five-week fiscal month of December and the 11-month year-to-date period ended December 31, 2016.
The Nasdaq reached a record high at Tuesday's close, but rising consumer confidence and positive housing-market data weren't enough to push the Dow Jones to 20,000.
The Dow's climb to 20,000 stalled Tuesday, but stocks remained somewhat higher. Consumer confidence is increasing, and housing prices are showing positive signs.
It has been quite a December for Fred's (FRED), one of the smaller U.S. pharmacy chains.
Stocks were slightly up on Tuesday as the Dow moves toward the 20,000 milestone and consumer confidence increases.
The company announced Tuesday that it would acquire 865 Rite Aid stores, but its recent earnings report was mediocre.
Fred's Inc. ("Fred's Pharmacy" or the "Company") (NASDAQ:FRED) today announced that its Board of Directors unanimously adopted a shareholder rights plan (the "Rights Plan").